College of Pharmacy mourns passing of James L. Winkle
The University of Cincinnati is saddened to share the passing of James L. Winkle, Class of 1958, namesake of the James L. Winkle College of Pharmacy, who peacefully passed away at age 88 in Hamilton, Ohio.
In 2005, he anonymously pledged $10 million to the College. He publicly acknowledged his gift in 2007 upon the urging of Daniel Acosta, who was dean at the time, in hopes that such a transformative gift would stimulate other alumni to realize the importance of supporting the College and raise its national profile. The College was renamed after Winkle the same year.
James L. Winkle. Photo provided.
Winkle told UC Magazine in 2007 that he didn't expect public recognition for his gift. He simply wanted to give back to the college.
"I think you reward those who have helped you, and this is my way of saying thank you to the College of Pharmacy," Winkle said.
Winkle's interest in pharmacy began at age 15 when he got a job in a local pharmacy, where a coworker was studying pharmacy at UC. "I worked mostly behind the soda fountain," Winkle said. "But pharmacy seemed like a good career, so that's what I pursued."
After graduating, Winkle worked at another Hamilton pharmacy, and when the owner died, he found himself handling day-to-day operations. He ran the pharmacy for several years before opening his own store — Winkle Discount Drug. Seven years later, Winkle sold his store to a chain to pursue a career in investing.
"The idea of becoming an investment adviser was very appealing," Winkle said. "I think being a businessman in pharmacy translated to being a good investment businessman. You have to learn to evaluate information and make decisions based on your investigation."
Winkle said that without his pharmacy degree, he is unsure what career he would have pursued and is grateful for the direction it took him. Winkle's passion for the College of Pharmacy never wavered, and faculty, staff and students are committed to carrying his legacy forward.
Current Dean Christopher Surratt last visited Winkle over the summer, at the invitation of Winkle's best friend and classmate Norm Dingeldein, Class of 1958.
“Jim’s health was poor then, but he seemed to enjoy our time together and wanted to hear the latest College doings,” Surratt said. “Norm visited Jim weekly and mentioned that the College was Jim’s passion. His donation has already helped the College compete for top-flight faculty candidates. We will do all we can to ensure that his gift is used to raise the James L. Winkle College of Pharmacy to new heights.”
Funeral arrangements for Winkle have yet to be announced.
Alyssa McKinney
Marketing Coordinator, James L. Winkle College of Pharmacy
Featured photo at top of the James L. Winkle College of Pharmacy. Photo/University of Cincinnati.
Tags
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.